CytRx Shareholders Get Del. Stock-Pump Suit Moving Again
A Delaware class case accusing biopharmaceutical company CytRx Corp.'s board of sanctioning a brazen stock-pumping scheme came off the bench Friday when a vice chancellor lifted a stay imposed in May...To view the full article, register now.
Already a subscriber? Click here to view full article